Cite
Aoki S, Yasui M, Tajirika H, et al. Pembrolizumab-Induced Severe Neuropathy in a Patient with Metastatic Urothelial Carcinoma after Achieving Complete Response: Guillain-Barré Syndrome-Like Onset. Case Rep Oncol. 2020;13(3):1490-1494doi: 10.1159/000511567.
Aoki, S., Yasui, M., Tajirika, H., Terao, H., Funahashi, M., & Ohta, J. (2020). Pembrolizumab-Induced Severe Neuropathy in a Patient with Metastatic Urothelial Carcinoma after Achieving Complete Response: Guillain-Barré Syndrome-Like Onset. Case reports in oncology, 13(3), 1490-1494. https://doi.org/10.1159/000511567
Aoki, Shuntaro, et al. "Pembrolizumab-Induced Severe Neuropathy in a Patient with Metastatic Urothelial Carcinoma after Achieving Complete Response: Guillain-Barré Syndrome-Like Onset." Case reports in oncology vol. 13,3 (2020): 1490-1494. doi: https://doi.org/10.1159/000511567
Aoki S, Yasui M, Tajirika H, Terao H, Funahashi M, Ohta J. Pembrolizumab-Induced Severe Neuropathy in a Patient with Metastatic Urothelial Carcinoma after Achieving Complete Response: Guillain-Barré Syndrome-Like Onset. Case Rep Oncol. 2020 Dec 17;13(3):1490-1494. doi: 10.1159/000511567. eCollection 2020. PMID: 33564288; PMCID: PMC7841730.
Copy
Download .nbib
